Variant report

Variant	esv3412612
Chromosome Location	chr11:8102026-8104049
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:140)
CpG islands
(count:488)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:140 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr11:8102356-8102660	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr11:8103306-8103389	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD2	chr11:8103357-8103451	HepG2	liver:	n/a	n/a
4	CHD2	chr11:8102455-8102492	H1-hESC	embryonic stem cell:	n/a	n/a
5	CREB1	chr11:8102469-8102915	A549	lung:	n/a	n/a
6	CTCF	chr11:8102547-8102581	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr11:8103420-8103570	AG10803	skin:	n/a	chr11:8103499-8103512
8	CTCF	chr11:8102537-8102539	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr11:8102500-8102650	HMEC	breast:	n/a	n/a
10	CTCF	chr11:8102440-8102590	HBMEC	blood vessel:	n/a	n/a
11	CTCF	chr11:8102460-8102610	HPF	lung:	n/a	n/a
12	CTCF	chr11:8102500-8102650	SK-N-SH_RA	brain:	n/a	n/a
13	CTCF	chr11:8102460-8102610	AG09319	gingival:	n/a	n/a
14	CTCF	chr11:8102480-8102630	GM12874	blood:	n/a	n/a
15	CTCF	chr11:8103380-8103530	AG04449	skin:	n/a	chr11:8103499-8103512
16	CTCF	chr11:8102480-8102630	AoAF	blood vessel:	n/a	n/a
17	CTCF	chr11:8102790-8102862	Kidney_OC	kidney:	n/a	n/a
18	CTCF	chr11:8103480-8103630	HFF	foreskin:	n/a	chr11:8103499-8103512
19	CTCF	chr11:8102575-8102615	LNCaP	prostate:	n/a	n/a
20	CTCF	chr11:8103420-8103570	AoAF	blood vessel:	n/a	chr11:8103499-8103512
21	CTCF	chr11:8102550-8102649	MCF-7	breast:	n/a	n/a
22	CTCF	chr11:8103200-8103350	AG04449	skin:	n/a	n/a
23	CTCF	chr11:8102519-8102665	SK-N-SH_RA	brain:	n/a	n/a
24	CTCF	chr11:8102500-8102650	AoAF	blood vessel:	n/a	n/a
25	CTCF	chr11:8102420-8102570	GM12871	blood:	n/a	n/a
26	CTCF	chr11:8102500-8102650	BJ	skin:	n/a	n/a
27	CTCF	chr11:8102558-8102584	Fibrobl	skin:	n/a	n/a
28	CTCF	chr11:8103380-8103530	AG10803	skin:	n/a	chr11:8103499-8103512
29	CTCF	chr11:8102500-8102650	HCPEpiC	choroid plexus:	n/a	n/a
30	CTCF	chr11:8102724-8102859	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTCF	chr11:8103240-8103390	NHDF-neo	bronchial:	n/a	n/a
32	CTCF	chr11:8102520-8102670	BJ	skin:	n/a	n/a
33	CTCF	chr11:8102480-8102630	AG09309	skin:	n/a	n/a
34	CTCF	chr11:8102400-8102550	HMF	breast:	n/a	n/a
35	CTCF	chr11:8102440-8102590	AG09319	gingival:	n/a	n/a
36	CTCF	chr11:8102520-8102670	HCM	heart:	n/a	n/a
37	CTCF	chr11:8102600-8102750	HEK293	kidney:	n/a	n/a
38	CTCF	chr11:8102500-8102650	HFF	foreskin:	n/a	n/a
39	CTCF	chr11:8102555-8102639	NHEK	skin:	n/a	n/a
40	CTCF	chr11:8103360-8103510	AG04450	lung:	n/a	n/a
41	CTCF	chr11:8102440-8102590	GM12873	blood:	n/a	n/a
42	CTCF	chr11:8102460-8102610	AG09309	skin:	n/a	n/a
43	CTCF	chr11:8103460-8103610	BJ	skin:	n/a	chr11:8103499-8103512
44	CTCF	chr11:8102576-8102618	GM12891	blood:	n/a	n/a
45	CTCF	chr11:8102500-8102650	AG04449	skin:	n/a	n/a
46	CTCF	chr11:8102560-8102575	GM12891	blood:	n/a	n/a
47	CTCF	chr11:8102460-8102610	HPAF	blood vessel:	n/a	n/a
48	CTCF	chr11:8102545-8102620	A549	lung:	n/a	n/a
49	CTCF	chr11:8102540-8102690	GM12868	blood:	n/a	n/a
50	E2F6	chr11:8102286-8102925	H1-hESC	embryonic stem cell:	n/a	chr11:8102415-8102424 chr11:8102601-8102610 chr11:8102440-8102447 chr11:8102766-8102777 chr11:8102439-8102447 chr11:8102767-8102782 chr11:8102431-8102446 chr11:8102439-8102447 chr11:8102438-8102448 chr11:8102766-8102777 chr11:8102804-8102813

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:8102510-8102560	HMEC	breast:	n/a
2	chr11:8102311-8102361	HEEpiC	esophagus:	n/a
3	chr11:8102311-8102361	CMK	blood:	n/a
4	chr11:8102450-8102500	GM12878	blood:	n/a
5	chr11:8102016-8102066	SK-N-MC	brain:	n/a
6	chr11:8102717-8102767	HEK293	kidney:	embryo
7	chr11:8103101-8103151	HNPCEpiC	eye:	n/a
8	chr11:8102016-8102066	T-47D	breast:	n/a
9	chr11:8102311-8102361	HRPEpiC	eye:	n/a
10	chr11:8102717-8102767	GM06990	blood:	n/a
11	chr11:8102510-8102560	GM12891	blood:	n/a
12	chr11:8102475-8102525	ECC-1	luminal epithelium:	n/a
13	chr11:8102717-8102767	AG04449	skin:	fetal
14	chr11:8102717-8102767	NB4	blood:	n/a
15	chr11:8102510-8102560	HCF	heart:	n/a
16	chr11:8102311-8102361	AG09319	gingival:	n/a
17	chr11:8102450-8102500	SKMC	muscle:	n/a
18	chr11:8102450-8102500	RPTEC	kidney:	n/a
19	chr11:8102016-8102066	NT2-D1	testis:	n/a
20	chr11:8102510-8102560	PrEC	prostate:	n/a
21	chr11:8103101-8103151	Hela-S3	cervix:	n/a
22	chr11:8102016-8102066	ovcar-3	ovarian:	n/a
23	chr11:8102510-8102560	SK-N-MC	brain:	n/a
24	chr11:8102717-8102767	SK-N-MC	brain:	n/a
25	chr11:8102311-8102361	K562	blood:	n/a
26	chr11:8102475-8102525	NHDF-neo	bronchial:	n/a
27	chr11:8102717-8102767	ovcar-3	ovarian:	n/a
28	chr11:8102450-8102500	PFSK-1	brain:	n/a
29	chr11:8103017-8103067	HCPEpiC	choroid plexus:	n/a
30	chr11:8102475-8102525	GM19239	blood:	n/a
31	chr11:8102510-8102560	ovcar-3	ovarian:	n/a
32	chr11:8102016-8102066	HCPEpiC	choroid plexus:	n/a
33	chr11:8102475-8102525	U87	brain:	n/a
34	chr11:8102450-8102500	HNPCEpiC	eye:	n/a
35	chr11:8102016-8102066	HEEpiC	esophagus:	n/a
36	chr11:8102717-8102767	NHDF-neo	bronchial:	n/a
37	chr11:8102717-8102767	SAEC	small airway:	n/a
38	chr11:8102717-8102767	SK-N-SH_RA	brain:	n/a
39	chr11:8103101-8103151	CMK	blood:	n/a
40	chr11:8103017-8103067	AG10803	skin:	n/a
41	chr11:8102475-8102525	ovcar-3	ovarian:	n/a
42	chr11:8102475-8102525	HCM	heart:	n/a
43	chr11:8103101-8103151	HCF	heart:	n/a
44	chr11:8103017-8103067	GM12878	blood:	n/a
45	chr11:8103017-8103067	CMK	blood:	n/a
46	chr11:8102717-8102767	HNPCEpiC	eye:	n/a
47	chr11:8102311-8102361	AG09309	skin:	n/a
48	chr11:8102016-8102066	MCF-7	breast:	n/a
49	chr11:8103101-8103151	Hepatocyte	liver:	n/a
50	chr11:8102717-8102767	NT2-D1	testis:	n/a

No data

Variant related genes	Relation type
TUB	TF binding region
TUB	CpG island

Extended variants
information (count: 87 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:87 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs189849938	chr11:8102056-8102057	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
2	rs544370574	chr11:8102077-8102078	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs116536667	chr11:8102095-8102096	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs577874979	chr11:8102103-8102104	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs76523607	chr11:8102118-8102119	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs541459814	chr11:8102121-8102122	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs573928241	chr11:8102125-8102126	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs377489872	chr11:8102126-8102127	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs145904576	chr11:8102139-8102140	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs562807964	chr11:8102141-8102142	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs370688638	chr11:8102144-8102145	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs112986136	chr11:8102166-8102167	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs531866005	chr11:8102197-8102198	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs550749977	chr11:8102205-8102206	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs192604224	chr11:8102227-8102228	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs372726871	chr11:8102228-8102229	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs533204582	chr11:8102238-8102239	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs546577474	chr11:8102239-8102240	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs138720801	chr11:8102299-8102300	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs535070419	chr11:8102306-8102307	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs548981703	chr11:8102310-8102311	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs568810582	chr11:8102314-8102315	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs142713726	chr11:8102321-8102322	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs557469895	chr11:8102325-8102326	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs577811733	chr11:8102366-8102367	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs184534277	chr11:8102378-8102379	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs554153111	chr11:8102406-8102407	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs574292283	chr11:8102426-8102427	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs189108787	chr11:8102471-8102472	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs61590653	chr11:8102479-8102480	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs555113465	chr11:8102529-8102530	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs112349881	chr11:8102558-8102559	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs576567703	chr11:8102644-8102645	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs545511257	chr11:8102738-8102739	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs7946342	chr11:8102741-8102742	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs113766217	chr11:8102815-8102816	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs546787101	chr11:8102904-8102905	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs560157089	chr11:8103001-8103002	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs563230517	chr11:8103014-8103015	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs376341951	chr11:8103021-8103022	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs112885280	chr11:8103050-8103051	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs375671199	chr11:8103099-8103100	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs11041733	chr11:8103104-8103105	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs189235110	chr11:8103131-8103132	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs551039467	chr11:8103134-8103135	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs571043906	chr11:8103163-8103164	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs534093009	chr11:8103172-8103173	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs554366598	chr11:8103182-8103183	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs370920538	chr11:8103185-8103186	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs567816720	chr11:8103192-8103193	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Neuroblastoma	18923191	CNVD
Breast cancer	19432969	CNVD
Alzheimer''s disease	17576883	CNVD
Long-qt syndrome	17576883	CNVD
Emphysema	19352772	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Chordoma	18071362	CNVD
Breast cancer	16608533	CNVD
Cancer	21183584	CNVD
Gastric adenocarcinoma	19115996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Myelofibrosis	22110671	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Neuroblastoma	21124317	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Schizophrenia	21399695	CNVD
Gastric cancer	16891809	CNVD
Cancer	17160897	CNVD
Multiple myeloma	16616336	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Dysmorphic features	22052655	CNVD
Intellectual disability	22052655	CNVD
Obesity	22052655	CNVD
Prostate cancer	18632612	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:406 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:8100400-8102200	Weak transcription	Pancreas	Pancrea
2	chr11:8101600-8102200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
3	chr11:8101600-8102200	Bivalent Enhancer	HepG2	liver
4	chr11:8101800-8102200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr11:8101800-8102200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
6	chr11:8101800-8102200	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
7	chr11:8101800-8102200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
8	chr11:8101800-8102200	Flanking Active TSS	Brain Cingulate Gyrus	brain
9	chr11:8101800-8102200	Enhancers	Brain Inferior Temporal Lobe	brain
10	chr11:8101800-8102200	Bivalent Enhancer	Fetal Muscle Leg	muscle
11	chr11:8101800-8102200	Enhancers	Ovary	ovary
12	chr11:8101800-8103400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
13	chr11:8102000-8102200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
14	chr11:8102000-8102200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr11:8102000-8102200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
16	chr11:8102000-8102200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
17	chr11:8102000-8102200	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr11:8102000-8102200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
19	chr11:8102000-8102200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
20	chr11:8102000-8102200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr11:8102000-8102200	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr11:8102000-8102200	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr11:8102000-8102200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
24	chr11:8102000-8102200	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr11:8102000-8102200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr11:8102000-8102200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
27	chr11:8102000-8102200	Enhancers	Adipose Nuclei	Adipose
28	chr11:8102000-8102200	Bivalent Enhancer	Brain Hippocampus Middle	brain
29	chr11:8102000-8102200	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
30	chr11:8102000-8102200	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
31	chr11:8102000-8102200	Bivalent Enhancer	Fetal Intestine Small	intestine
32	chr11:8102000-8102200	Flanking Bivalent TSS/Enh	Fetal Lung	lung
33	chr11:8102000-8102200	Bivalent Enhancer	Placenta	Placenta
34	chr11:8102000-8102200	Bivalent Enhancer	Fetal Stomach	stomach
35	chr11:8102000-8102200	Enhancers	Right Ventricle	heart
36	chr11:8102000-8102200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
37	chr11:8102000-8102200	Enhancers	A549	lung
38	chr11:8102000-8102400	Bivalent/Poised TSS	Brain Germinal Matrix	brain
39	chr11:8102000-8102600	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr11:8102000-8102600	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr11:8102000-8102600	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr11:8102000-8102600	Flanking Active TSS	Fetal Brain Male	brain
43	chr11:8102000-8102600	Enhancers	Fetal Heart	heart
44	chr11:8102000-8102600	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
45	chr11:8102000-8102600	Flanking Active TSS	Stomach Smooth Muscle	stomach
46	chr11:8102000-8103200	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr11:8102000-8103200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
48	chr11:8102000-8103200	Active TSS	Brain Anterior Caudate	brain
49	chr11:8102000-8103200	Active TSS	Colon Smooth Muscle	Colon
50	chr11:8102000-8103200	Active TSS	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links